Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.62) per share for the quarter.
Rapport Therapeutics Price Performance
Shares of NASDAQ RAPP opened at $11.78 on Wednesday. The business has a 50-day simple moving average of $15.86 and a two-hundred day simple moving average of $19.76. Rapport Therapeutics has a fifty-two week low of $11.43 and a fifty-two week high of $29.74.
About Rapport Therapeutics
See Also
- Five stocks we like better than Rapport Therapeutics
- How to find penny stocks to invest and trade
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Technology Stocks Explained: Here’s What to Know About Tech
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Rapport Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapport Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
